Cite
HARVARD Citation
Matthews, R. et al. (2023). A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection. Journal of acquired immune deficiency syndromes. pp. 310-316. [Online].